2seventy bio
TSVT
TSVT was delisted on the 13th of May, 2025.
128 hedge funds and large institutions have $816M invested in 2seventy bio in 2021 Q4 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
174% more call options, than puts
Call options by funds: $1.83M | Put options by funds: $668K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$73.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$65.2M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$59.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$58M |
| 5 |
BlackRock
New York
|
+$50M |
Top Sellers
TSVT Hedge Fund Activity: Q4 2021 in Review
128 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q4 2021, worth a combined $816M.
Buyers outnumbered sellers: 128 funds opened new TSVT positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was State Street, opening a new position worth an estimated $73.7M.
- 128 institutional investors held 2seventy bio (TSVT) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $816M of 2seventy bio stock for Q4 2021.
- 128 funds opened new 2seventy bio positions in Q4 2021 and 0 closed out, a net change of +128 holders.
- The largest 2seventy bio buyer in Q4 2021 was State Street, an estimated $73.7M added.
Based on aggregated 13F filings for Q4 2021.